Il Yang to sell a non-medicated anti-hypertension device.
RESPeRATE was approved by the U. S. FDA as an anti-hypertension device showing no any adverse reactions with clinically proven efficacy.
The Israeli compa...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
